PCM
PRAH

Price Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Price Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,100
Closed -$121K – 51
2018
Q3 		$121K Buy
+1,100
New +$115K 0.04% 53

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Price Capital Management's PRAH Position: Q4 2018 in Review

Price Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2018, closing a stake of 1,100 shares — an estimated $121K sold.

Price Capital Management first reported a position in PRAH in Q3 2018 and held it in 1 quarter. The position peaked at $121K in Q3 2018. 334 funds tracked by Wall St. Rank hold PRAH as of Q4 2018.

  • Price Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q4 2018 after selling out during the quarter.
  • Price Capital Management sold 1,100 PRA Health Sciences, Inc. shares in Q4 2018, an estimated $121K.
  • Price Capital Management first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 1 quarter.
  • Price Capital Management's PRA Health Sciences, Inc. position peaked at $121K in Q3 2018.
  • 334 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2018.

Based on Price Capital Management's 13F filing for Q4 2018, filed 15 Jan 2019.